CJC-1295/Ipamorelin [5mg/5mg]

Synergistic Growth Hormone Secretagogue Blend | GH Release & Regeneration Research | USA Manufactured & Third-Party Tested

CJC-1295/Ipamorelin is a research peptide combination designed to provide a dual pathway approach to stimulating endogenous growth hormone (GH) release.

• CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), studied for its ability to promote long-lasting increases in GH and IGF-1 levels.

• Ipamorelin is a selective ghrelin receptor agonist and growth hormone secretagogue, valued for its targeted GH stimulation with minimal off-target effects.

When studied together, these compounds have become a point of interest in research related to cellular regeneration, tissue repair, metabolism, and age-related studies.

Each vial contains 5mg of CJC-1295 and 5mg of Ipamorelin, provided as a lyophilized powder for maximum stability. Manufactured in a U.S. facility and third-party tested for >99% purity, this combination offers consistent quality for advanced research applications.

Key Features

• 5mg CJC-1295 + 5mg Ipamorelin per vial

• Dual-action GH secretagogue blend

• Manufactured in the USA (cGMP-compliant facility)

• Third-party tested for >99% purity and identity

• Supports studies in GH release, tissue regeneration, and longevity research

• For research use only – not for human consumption

Disclaimer: This compound is intended strictly for laboratory research purposes only. It is not a drug, food, or cosmetic, and is not intended for human use or consumption in any form.